JB/CALL/POLE GROU/18/0.1667/21.03.25 Stock JB/CALL/POLE GROU/18/0.1667/21.03.25
Add to a list
To use this feature you must be a member
Log inSign up

JB/CALL/POLE GROU/18/0.1667/21.03.25 Share Price

Warrant

PPZRJB

CH1311824036

Market Closed - Swiss Exchange 08:50:00 01/07/2024 pm IST
2.16 CHF +0.47% Intraday chart for JB/CALL/POLE GROU/18/0.1667/21.03.25
Current month+0.47%
1 month-23.94%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart POLYPEPTIDE GROUP AG
Chart JB/CALL/POLE GROU/18/0.1667/21.03.25

Latest news about POLYPEPTIDE GROUP AG

PolyPeptide : and Donaldson collaborate to develop solvent recovery system for peptide purification PU
Donaldson Company, Inc. and PolyPeptide Group AG Partners to Improve Sustainability in Peptide Manufacturing with Solvent Recovery Technology CI
Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group AQ
PolyPeptide announces results of the annual General Meeting 2024 EQ
More news

Quotes 5-day view

Date Price Change
01/24/01 2.16 +0.47%
28/24/28 2.15 -4.44%
27/24/27 2.25 +0.90%
26/24/26 2.23 -4.70%
25/24/25 2.34 -5.65%

Delayed Quote Swiss Exchange

Last update July 01, 2024 at 08:50 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying POLYPEPTIDE GROUP AG
Issuer Bank Julius Bär
PPZRJB
ISINCH1311824036
Date issued 21/12/2023
Strike 18 CHF
Maturity 21/03/2025 (263 Days)
Parity 6 : 1
Emission price 0.68 CHF
Emission volume N/A
Settlement les deux
Currency CHF

Technical Indicators

Highest since issue 2.9 CHF
Lowest since issue 0.45 CHF
Delta0.85x
Omega 1.889
Premium7.78x
Gearing2.21x
Moneyness 1.597
Difference Strike -10.6 CHF
Difference Strike %-58.89%
Spread 0.01 CHF
Spread %0.46%
Theoretical value 2.165
Implied Volatility 78.85 %
Total Loss Probability 35.14 %
Intrinsic value 1.792
Present value 0.3730
Break even 30.99 CHF
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
More about the company

Ratings for PolyPeptide Group AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: PolyPeptide Group AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
29.51 EUR
Average target price
26.74 EUR
Spread / Average Target
-9.39%
Consensus
  1. Stock Market
  2. Warrants
  3. PPZRJB Warrant